|

Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis

RECRUITINGSponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna
Actively Recruiting
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2023-09-01
Est. completion2033-08-31
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06866912

Summary

observational epidemiological study of patients affected by systemic amyloidosis

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* patients diagnosed with amyloidosis or asymptomatic carriers of mutations in the transthyretin gene
* minimum age of 18 years at the time of diagnosis
* obtaining informed consent

Exclusion Criteria:

* nothing

Conditions2

CardiomyopathyHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.